MedTrace Logo

Maternal 25-hydroxy Vitamin D Level and Adverse Outcomes in Near Term and Full Term Neonates

NCT03451864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2018-03-02

No results posted yet for this study

Summary

Eighty-eight pregnant women and their newborns were enrolled in a cross-sectional study. Maternal serum 25-OHD was measured by ELISA

Conditions

  • Neonatal Outcome

Interventions

PROCEDURE

Vaginal delivery

classic vaginal delivery

PROCEDURE

Cesarean Section

routine lower segment cesarean scetion

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Maged, MD · professor

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2018-02-01
Completion
2018-02-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03451864 on ClinicalTrials.gov